rimary CNS lymphomas, a rare malignant form of non-Hodgkin's lymphoma, account for 3%-6% of all primary brain neoplasms. 4 There has been an increase in the incidence of malignant lymphoma in the last 3 decades. The differentiation of malignant lymphomas from gliomas or malignant gliomas by conventional MRI can be difficult. Malignant lymphomas and glioblastomas require different treatments; glioblastomas are treated by extensive resection, whereas malignant lymphomas are usually addressed by biopsy. Therefore, a differential diagnosis is of high clinical relevance. Moreover, even with advanced MRI techniques that yield physiological inabbreviatioNs ADC = apparent diffusion coefficient; ADCMIN = minimum absolute ADC; b-n = b value of n sec/mm 2 ; cho = choline; Cr = creatine; DWI = diffusionweighted imaging; FLAIR = fluid-attenuated inversion recovery;
formation, it is often difficult to differentiate malignant lymphomas from nonneoplastic diseases such as neuroBehçet disease, multiple sclerosis, and acute demyelinating encephalomyelitis.
Magnetic resonance spectroscopy (MRS) is a noninvasive technique for obtaining biochemical information from the volume of interest (VOI) in tissues. 8, 23 In vivo proton MRS ( 1 H-MRS) provides important information on tumor activity and tumor-tissue characteristics. The usefulness of 1 H-MRS parameters in the differential diagnosis of brain tumors has been reported. 1, 14 Among these parameters, lipid peaks can be effectively detected, especially at a short echo time. In brain tumors, the presence of lipids often indicates the presence of necrotic tissue, which is considered to be an indicator of malignancy and a poor prognosis. 17, 29, 36 Because malignant brain tumors tend to exhibit central necrosis on Gd-enhanced T1-weighted images, central necrosis inside the VOI is reflected by lipid peaks on 1 H-MRS images. For the analysis of specific tumor characteristics, it is important to select the VOI only in Gd-enhanced lesions. However, because the signal-tonoise ratio from the pixel level of the VOI is low, it is difficult to avoid signals from necrotic or cystic lesions even when using the multivoxel 1 
H-MRS technique.
We used Gd-enhanced MRI to establish a differential diagnosis between malignant lymphomas and gliomas without central necrosis or cystic changes and examined the diagnostic value of 1 H-MRS from the perspective of lipid peaks. We found that the presence on short echo time 
methods patients
This retrospective study was approved by the Hiroshima University Hospital's institutional review board; the requirement for written patient consent was waived. To protect patient privacy, we removed all identifiers from our records after the completion of our analyses.
Between 2007 and 2013, we treated 30 patients with malignant lymphoma at our institution. We excluded 13 tumors because they were metastatic malignant lymphomas (n = 7) or their size was too small for setting a VOI (n = 6). Consequently, 17 malignant lymphomas (in 6 males and 11 females), 2 of which were tumors with central necrosis, were included in the study. The 15 lymphomas without central necrosis were homogeneously enhanced on T1-weighted images; they were the focus of this study.
In that same period, we also treated 143 patients with a newly diagnosed surgically confirmed glioma. We excluded 21 tumors because they were not examined by 1 H-MRS (n = 12), their size was too small for setting a VOI (n = 3), or their spectra were of poor quality (n = 6), as indicated by an increased line width of the water resonance by 3 or more SDs above the mean line width of all tumor spectra. 27, 34 Consequently, our study included 122 gliomas (in 71 males and 51 females); 7 were homogeneously enhanced on T1-weighted images and were the focus of this study.
mri studies
All MRI studies were performed using a 3. Diffusion-weighted imaging (DWI) was performed with b values of 1000 and 4000 sec/mm 2 (b-1000 and b-4000, respectively). The effective gradient was 40 mT/m, and the slew rate was 150 mT/m/msec. We used an 8-channel phased-array head coil with the following imaging parameters: TR 5000 msec and TE 73.2 msec (b-1000), TR 5000 msec and TE 100 msec (b-4000), number of excitations 1, FOV 22 × 22 cm, slice thickness 6 mm, intersection gap 1.0 mm, number of slices 20, data acquisition matrix 128 × 128, and 2 acquisitions. The scan times were 20 and 40 seconds for b-1000 and b-4000, respectively.
Transverse, sagittal, and coronal spin-echo T1-weighted images were acquired after the intravenous administration of a Gd-based contrast medium and using the following parameters: TR 450 msec, TE 18 msec, FOV 18 × 18 cm, matrix size 288 × 192, section thickness 6 mm, intersection gap 1.0 mm, and 2 acquisitions. The Gd-enhanced pattern of each tumor was defined as having no, focal, heterogeneous, ring, or homogeneous enhancement.
proton mrs
For 1 H-MRS, we applied the point-resolved spectroscopic method (probe-P; TR 2000 msec, TE 144 msec, 2048 data points, 64 signals acquired) with a circularly polarized head coil. Additional spectra with a short (30-msec) TE were also acquired. To guide the single-voxel spectroscopic examinations, we used enhanced T1-weighted images for enhanced tumors and T2-weighted FLAIR images for nonenhanced tumors. Under 3D control, the rectangular 1 H-MRS voxel was placed on the solid tumor area; efforts were made to avoid contamination by surrounding normal-appearing tissue, the skull base, any hemorrhagic lesions, and the ventricular system and to include enhanced tumor lesions in patients with an enhanced tumor and FLAIR high-intensity lesions in patients with a nonenhanced tumor. The voxel size was between 15 × 15 × 15 mm (volume 3.4 cm water proton and optimization of water suppression were performed, resulting in water-peak line widths of 2-4 Hz. All MR images covering the VOI selected for MRS were retrospectively assessed consensually by 3 of the authors (F.Y., T.T., and R.N.). Spectra of poor quality, 27, 34 identified by an increased line width of the water resonance (a measure of the field homogeneity in the VOI) of 3 or more SDs above the mean line width of all tumor spectra, were excluded from the final analyses. The line width of the water signal intensity was automatically measured and reported by the processing software. The relative signal intensities of choline (Cho), creatine (Cr), N-acetyl aspartate (NAA), and myoinositol (mI) were obtained by numeric integration of the fitted signals. The signals of lipid peaks were determined by their short TEs, because the relaxation time of a lipid is very short. Lipid peaks were defined as negative and undetectable (-), positive and detectable (1+), strongly positive (2+, representing the second largest among all the peaks), and extremely strongly positive (3+, representing the largest among all the peaks).
Apparent Diffusion Coefficient Maps and Calculations
All apparent diffusion coefficient (ADC) maps were generated with software (FuncTool; GE Medical Systems). 
Histological Study
Tumor specimens obtained by resection or biopsy were fixed in 10% phosphate-buffered formalin and embedded in paraffin. Representative slides were stained with H & E for a standard histological diagnosis according to WHO criteria by the consensus of 2 of the authors (V.J.A. and Y.T.), who were blinded to all clinical and radiological data. 
Statistical Analysis
Statistical analyses were performed with StatView software (version 5.0; SAS Institute). The relationship between MRS parameters that included the NAA-to-Cr, Cho-to-Cr, Cho-to-NAA, and mI-to-Cr ratios, the lipid levels, the averaged ADCs, and the different brain tumor types was evaluated with logistic analysis, the chi-square test, and the Mann-Whitney U-test; statistical significance was assigned when the p value was < 0.05.
results patients and glioma grades
The patients with a malignant lymphoma or glioma ranged in age from 36 to 78 years (mean 63.9 years, median 66 years) and from 1 to 85 years (mean 46.5 years, median 48.5 years), respectively. Of the 122 gliomas, 49 were Grade IV (47 glioblastomas and 2 gliosarcomas), 33 were Grade III (12 anaplastic astrocytomas, 12 anaplastic oligoastrocytomas, 8 anaplastic oligodendrogliomas, 1 anaplastic pleomorphic xanthoastrocytoma), 30 were Grade II (5 diffuse astrocytomas, 13 oligoastrocytomas, 8 oligodendrogliomas, 3 pilomyxoid astrocytomas, and 1 pleomorphic xanthoastrocytoma), and 10 were Grade I (8 pilocytic astrocytomas, 1 ganglioglioma, and 1 papillary glioneuronal tumor).
Gadolinium enhancement was absent in 21, focal in 21, heterogeneous in 25, and homogeneous in 7 of the 122 gliomas; 47 were ring enhanced. For 1 patient with a glioblastoma and renal failure, we did not attempt to obtain enhanced images; the VOI was chosen on T2-weighted FLAIR images.
Lipid Peaks Detected by Single-Voxel
1 h-mrs We first analyzed the lipid peaks of gliomas and lymphomas seen in 1 H-MRS images (Table 1 ). In each of the 17 malignant lymphomas, we observed strong-positive (2+) or extremely strong-positive (3+) lipid peaks. Of the 122 Grade I-IV gliomas, 52 (42.6%) manifested 2+ or 3+ lipid peaks.
Although lipid peaks were rare in lower-grade gliomas, we observed 2+ and 3+ peaks in 30.3% of the Grade III and 79.6% of the Grade IV gliomas (low-vs high-grade gliomas, p < 0.0001, chi-square test; Grade III vs IV, p < 0.0001, chi-square test). No unenhanced gliomas showed lipid peaks. The expression of 2+ or 3+ lipid peaks was statistically higher in malignant lymphomas than in highgrade gliomas (p = 0.0014, chi-square test).
H-MRS Findings in Ring-Enhanced Tumors
Next, we focused on ring-enhanced tumors ( Table 2 ). Both of the ring-enhanced malignant lymphomas showed 3+ lipid peaks. We observed 2+ or 3+ lipid peaks in 43 of the 46 ring-enhanced gliomas. All but one glioma, a ringenhanced pilocytic astrocytoma, showed lipid peaks.
H-MRS Findings of Homogeneously Enhanced Tumors
We then focused on the patients with homogeneously enhanced lymphomas and gliomas. Our MRS findings on malignant lymphomas and gliomas without central necrosis are summarized in Table 3 . All of the malignant lymphomas but none of the gliomas showed 2+ or 3+ lipid expression (Figs. 1 and 2) Table 3 . Comparisons at b-1000 and b-4000 showed that the ADC MIN values of gliomas were higher than those of malignant lymphomas (p = 0.0220 and 0.0010, respectively, Mann-Whitney U-test) (Fig. 6) . However, there was some overlap between gliomas and malignant lymphomas at both b values.
Discussion
Our results show that high lipid peaks in tumors without central necrosis are a characteristic of malignant lymphomas and that their absence in intraaxial tumors without central necrosis is strongly suggestive of glioma. Although others reported that malignant lymphomas demonstrated massively elevated lipid resonances, some patients with high-grade gliomas, including glioblastomas, manifested high lipid peaks. 3, 7, 12, 16, 25, 36 Our findings on Grade I-IV gliomas, especially ring-enhanced glioblastomas, are consistent with theirs. The earlier studies did not focus on homogeneously enhanced lesions; rather, they analyzed heterogeneously enhanced, ring-enhanced, and nonenhanced tumors together. Although it is important to set the ROI on enhanced tumor lesions and to avoid placement on nonenhanced lesions (e.g., areas of central necrosis), it can be difficult. Therefore, we focused on tumors without central necrosis (i.e., homogeneously enhanced tumors). We found that there was a characteristic difference in the presence and size of lipid resonance peaks on 1 H-MRS images between homogeneously enhanced gliomas and malignant lymphomas. Consequently, although our and earlier studies showed a statistically significant difference in lipid expression between malignant lymphomas and high-grade gliomas, our findings on homogeneously enhanced tumors show that lipid expression differentiates between malignant lymphomas and high-grade gliomas. This finding is clinically relevant because homogeneously enhanced gliomas can be differentiated from malignant lymphomas by the absence of high lipid resonance peaks on 1 H-MRS images. 
high lipid levels in malignant lymphoma on 1 h-mrs
The detection of high lipid peaks in malignant lymphomas has been suggested to reflect a high cell turnover and infiltration by macrophages. 13 The high lipid levels in these tumors without necrosis may be caused by the presence of activated or transformed lymphocytes or macrophages, because these cell types can contain high levels of MR-visible lipids. 18, 19 Primary CNS lymphomas are hypercellular and comprise lymphoid cells and macrophages. 21 Phagocytosis of cell membranes by infiltrated macrophages results in lipid signals. 9 Lipid signals have also been attributed to in vivo apoptosis or programmed cell death. 30 Fluorescence microscopy and flow-cytometry measurements have shown that an increase in 1 H-MRSdetectable lipids was correlated with an accumulation of cytoplasmic lipid droplets, the so-called lipid bodies. 5, 11 Lipid signals in most brain tumors can be observed when the spectra are acquired at a TE of < 50 msec. Mobile lipid resonances are generally observed in contrast-enhancing and necrotic areas of the tumor. Brain tumors tend to be highly heterogeneous and include areas of viable tumor, necrosis, and hemorrhage. Elevated lipid peaks are a characteristic of solid and cystic high-grade gliomas but not of high lipid levels in malignant lymphoma on 1 h-mrs low-grade gliomas. 2, 22, 26, 28, 29, 33 Among our homogeneously enhanced gliomas, low-and high-grade tumors did not differ with respect to lipid peaks, which suggests that the higher lipid peaks in high-grade gliomas may be attributable to their cystic or necrotic components. Future studies are necessary to assess the relationship between the size of lipid peaks and glioma grade.
The minimum or mean ADCs of malignant lymphomas are statistically lower than those of gliomas. 6, 10, 15, 20, 32, 35, 37 The sensitivity and specificity of the ADC for discriminating between malignant lymphomas and gliomas are approximately 80%-90%. However, some studies reported no statistically significant difference in the ADCs of glioblastomas and malignant lymphomas, although the ADCs of malignant lymphomas were lower than those of highgrade gliomas. 24, 31 In fact, the overlap in ADC values rendered the differentiation between malignant lymphomas and gliomas on the basis of the ADC difficult. 20, 31, 35 For better and more accurate differentiation, other methods (e.g., fractional anisotropy, 32 perfusion-weighted imaging, 37 MRS, and PET imaging 24, 37 ) were added to the ADC parameters. Although they were useful, some overlapping between the malignant lymphomas and gliomas persisted. A differential diagnostic advantage of higher b-valuebased DWI in many CNS diseases, including malignant lymphomas, has been reported. 6 Although we found that b-4000-based DWI was superior to b-1000-based DWI, it was not possible to differentiate all malignant lymphomas from gliomas even with the higher b value.
Our study has some limitations. We focused strictly on the differentiation between malignant lymphomas and gliomas. We did not include tumefactive demyelinating lesions or metastatic tumors in our analysis because, at our institution, all metastatic tumors larger than 2 cm contained some cystic formations or central necrosis. We could not apply our single-voxel 1 H-MRS method to study small tumors. Future studies are necessary to confirm the lipid expression of homogeneously enhanced metastases. Although here we used qualitative rather than quantitative methods to evaluate lipid signals, quantitative studies using LCModel software are in progress in our laboratory. 
Conclusions

